| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.876 | 0.005 | 0.876 | Analgesic | 0.871 0.005 DBMET00341 0.382 0.092 DBMET02568 0.807 0.005 DBMET02569 0.785 0.007 DBMET02570 | ||
| 0.742 | 0.003 | 0.742 | Anesthetic general | 0.561 0.005 DBMET00341 0.362 0.022 DBMET02568 0.65 0.004 DBMET02569 0.458 0.011 DBMET02570 | ||
| 0.733 | 0.003 | 0.733 | Sigma receptor antagonist | 0.394 0.005 DBMET00341 0.346 0.005 DBMET02568 0.553 0.004 DBMET02569 0.159 0.01 DBMET02570 | ||
| 0.666 | 0.003 | 0.666 | Analgesic, opioid | 0.632 0.003 DBMET00341 0.114 0.025 DBMET02568 0.539 0.004 DBMET02569 0.476 0.004 DBMET02570 | ||
| 0.646 | 0.005 | 0.68 | Potassium channel (Voltage-sensitive) blocker | 0.368 0.032 DBMET00341 0.68 0.005 DBMET02568 0.553 0.01 DBMET02569 0.26 0.063 DBMET02570 | DBMET02568 | |
| 0.627 | 0.007 | 0.712 | HERG channel blocker | 0.312 0.046 DBMET00341 0.712 0.005 DBMET02568 0.528 0.013 DBMET02569 0.216 0.081 DBMET02570 | DBMET02568 | |
| 0.56 | 0.017 | 0.56 | Spasmolytic | 0.353 0.052 DBMET00341 0.354 0.051 DBMET02568 0.555 0.017 DBMET02569 0.349 0.053 DBMET02570 | ||
| 0.541 | 0.004 | 0.541 | Anesthetic local | 0.361 0.008 DBMET00341 0.135 0.057 DBMET02568 0.389 0.007 DBMET02569 0.251 0.02 DBMET02570 | ||
| 0.516 | 0.01 | 0.563 | Potassium channel blocker | 0.27 0.057 DBMET00341 0.563 0.007 DBMET02568 0.415 0.02 DBMET02569 0.167 0.118 DBMET02570 | DBMET02568 | |
| 0.499 | 0.003 | 0.499 | Opioid mu receptor agonist | 0.443 0.003 DBMET00341 0.041 0.04 DBMET02568 0.33 0.004 DBMET02569 0.27 0.004 DBMET02570 | ||
| 0.492 | 0.004 | 0.492 | Opioid antagonist | 0.388 0.005 DBMET00341 0.114 0.039 DBMET02568 0.324 0.005 DBMET02569 0.239 0.009 DBMET02570 | ||
| 0.494 | 0.01 | 0.543 | Sigma receptor agonist | 0.543 0.006 DBMET02568 0.419 0.019 DBMET02569 | DBMET02568 | |
| 0.475 | 0.004 | 0.475 | Opioid agonist | 0.437 0.004 DBMET00341 0.049 0.041 DBMET02568 0.304 0.004 DBMET02569 0.252 0.005 DBMET02570 | ||
| 0.466 | 0.004 | 0.466 | Opioid mu receptor antagonist | 0.377 0.004 DBMET00341 0.086 0.037 DBMET02568 0.305 0.005 DBMET02569 0.224 0.007 DBMET02570 | ||
| 0.439 | 0.038 | 0.619 | 5 Hydroxytryptamine release stimulant | 0.619 0.013 DBMET00341 0.548 0.02 DBMET02568 0.216 0.109 DBMET02569 0.403 0.045 DBMET02570 | DBMET00341 | |
| 0.35 | 0.005 | 0.35 | Opioid kappa receptor antagonist | 0.251 0.007 DBMET00341 0.109 0.029 DBMET02568 0.24 0.007 DBMET02569 0.143 0.018 DBMET02570 | ||
| 0.34 | 0.006 | 0.364 | Neurotrophic factor | 0.222 0.019 DBMET00341 0.179 0.038 DBMET02568 0.364 0.005 DBMET02569 0.251 0.012 DBMET02570 | DBMET02569 | |
| 0.347 | 0.021 | 0.347 | P-glycoprotein inhibitor | 0.149 0.118 DBMET00341 0.198 0.065 DBMET02568 0.324 0.025 DBMET02569 0.152 0.114 DBMET02570 | ||
| 0.331 | 0.011 | 0.331 | Neuropeptide Y2 antagonist | 0.314 0.014 DBMET00341 0.245 0.062 DBMET02568 0.294 0.022 DBMET02569 0.276 0.034 DBMET02570 | ||
| 0.307 | 0.009 | 0.371 | Acetylcholine muscarinic antagonist | 0.217 0.02 DBMET00341 0.18 0.03 DBMET02568 0.371 0.005 DBMET02569 0.265 0.012 DBMET02570 | DBMET02569 | |
| 0.288 | 0.004 | 0.288 | Acetylcholine M2 receptor antagonist | 0.188 0.007 DBMET00341 0.082 0.028 DBMET02568 0.186 0.008 DBMET02569 0.125 0.015 DBMET02570 | ||
| 0.287 | 0.004 | 0.314 | Opioid delta receptor agonist | 0.314 0.004 DBMET00341 0.136 0.005 DBMET02569 0.139 0.005 DBMET02570 | DBMET00341 | |
| 0.285 | 0.005 | 0.285 | Opioid delta receptor antagonist | 0.246 0.006 DBMET00341 0.054 0.05 DBMET02568 0.209 0.01 DBMET02569 0.175 0.015 DBMET02570 | ||
| 0.32 | 0.048 | 0.32 | Cardiotonic | 0.19 0.128 DBMET02568 0.27 0.07 DBMET02569 | ||
| 0.284 | 0.012 | 0.284 | Calcium channel blocker | 0.171 0.044 DBMET00341 0.164 0.048 DBMET02568 0.238 0.019 DBMET02569 0.141 0.067 DBMET02570 | ||
| 0.278 | 0.008 | 0.278 | Calcium channel (voltage-sensitive) blocker | 0.143 0.038 DBMET00341 0.141 0.039 DBMET02568 0.225 0.013 DBMET02569 0.119 0.058 DBMET02570 | ||
| 0.297 | 0.032 | 0.299 | 5 Hydroxytryptamine 1E antagonist | 0.263 0.061 DBMET00341 0.299 0.03 DBMET02568 | DBMET02568 | |
| 0.265 | 0.004 | 0.265 | Acetylcholine release stimulant | 0.155 0.014 DBMET00341 0.173 0.007 DBMET02568 0.222 0.004 DBMET02569 0.142 0.022 DBMET02570 | ||
| 0.244 | 0.005 | 0.323 | Acetylcholine M3 receptor antagonist | 0.152 0.011 DBMET00341 0.101 0.018 DBMET02568 0.323 0.004 DBMET02569 0.222 0.005 DBMET02570 | DBMET02569 | |
| 0.368 | 0.131 | 0.516 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.414 0.088 DBMET00341 0.516 0.027 DBMET02568 0.282 0.238 DBMET02569 0.33 0.174 DBMET02570 | DBMET02568 | |
| 0.281 | 0.044 | 0.33 | Tyrosine 3 hydroxylase inhibitor | 0.33 0.021 DBMET00341 0.297 0.034 DBMET02568 0.246 0.072 DBMET02569 0.291 0.038 DBMET02570 | DBMET00341 | |
| 0.255 | 0.02 | 0.327 | Cholinergic antagonist | 0.213 0.029 DBMET00341 0.169 0.043 DBMET02568 0.327 0.012 DBMET02569 0.271 0.018 DBMET02570 | DBMET02569 | |
| 0.252 | 0.02 | 0.321 | Acetylcholine antagonist | 0.211 0.028 DBMET00341 0.167 0.042 DBMET02568 0.321 0.012 DBMET02569 0.267 0.017 DBMET02570 | DBMET02569 | |
| 0.241 | 0.009 | 0.241 | Calcium channel N-type blocker | 0.189 0.019 DBMET00341 0.15 0.038 DBMET02568 0.214 0.014 DBMET02569 0.168 0.028 DBMET02570 | ||
| 0.232 | 0.009 | 0.232 | 5 Hydroxytryptamine 1 agonist | 0.07 0.028 DBMET00341 0.112 0.018 DBMET02568 0.09 0.023 DBMET02569 | ||
| 0.231 | 0.009 | 0.231 | 5 Hydroxytryptamine 1F antagonist | 0.134 0.02 DBMET00341 0.145 0.017 DBMET02568 0.109 0.028 DBMET02569 | ||
| 0.227 | 0.005 | 0.227 | Dopamine uptake inhibitor | 0.185 0.007 DBMET00341 0.086 0.023 DBMET02568 0.155 0.009 DBMET02569 0.128 0.013 DBMET02570 | ||
| 0.232 | 0.017 | 0.232 | Nav1.3 sodium channel blocker | 0.167 0.038 DBMET00341 0.106 0.09 DBMET02568 0.154 0.045 DBMET02569 0.105 0.092 DBMET02570 | ||
| 0.274 | 0.068 | 0.282 | Ca(v)3.3 blocker | 0.282 0.059 DBMET02568 0.233 0.128 DBMET02569 | DBMET02568 | |
| 0.242 | 0.043 | 0.267 | Neurotrophic factor enhancer | 0.267 0.03 DBMET02568 0.254 0.036 DBMET02569 | DBMET02568 | |
| 0.208 | 0.01 | 0.24 | 5 Hydroxytryptamine uptake inhibitor | 0.24 0.009 DBMET00341 0.07 0.039 DBMET02568 0.112 0.023 DBMET02569 0.124 0.02 DBMET02570 | DBMET00341 | |
| 0.202 | 0.014 | 0.202 | Neuropeptide Y antagonist | 0.175 0.017 DBMET00341 0.139 0.024 DBMET02568 0.079 0.059 DBMET02569 0.074 0.069 DBMET02570 | ||
| 0.2 | 0.018 | 0.319 | Alpha 2c adrenoreceptor antagonist | 0.126 0.045 DBMET00341 0.319 0.005 DBMET02568 0.096 0.07 DBMET02569 | DBMET02568 | |
| 0.193 | 0.019 | 0.234 | Alpha 2 adrenoreceptor antagonist | 0.162 0.024 DBMET00341 0.234 0.013 DBMET02568 0.078 0.068 DBMET02569 | DBMET02568 | |
| 0.173 | 0.003 | 0.173 | CC chemokine 5 receptor agonist | 0.137 0.005 DBMET00341 0.143 0.004 DBMET02568 0.132 0.005 DBMET02569 0.104 0.017 DBMET02570 | ||
| 0.201 | 0.034 | 0.201 | Nav1.2 sodium channel blocker | 0.127 0.075 DBMET00341 0.138 0.065 DBMET02568 0.181 0.042 DBMET02569 0.114 0.091 DBMET02570 | ||
| 0.248 | 0.082 | 0.257 | Gastrin inhibitor | 0.247 0.083 DBMET00341 0.244 0.086 DBMET02568 0.257 0.071 DBMET02569 0.256 0.072 DBMET02570 | DBMET02569 | |
| 0.179 | 0.015 | 0.22 | Multidrug resistance-associated protein 1 inhibitor | 0.22 0.007 DBMET02568 0.153 0.024 DBMET02569 | DBMET02568 | |
| 0.185 | 0.027 | 0.187 | Neuropeptide Y1 antagonist | 0.167 0.042 DBMET00341 0.187 0.025 DBMET02568 0.14 0.082 DBMET02569 | DBMET02568 | |
| 0.268 | 0.116 | 0.298 | Vasodilator, coronary | 0.221 0.163 DBMET00341 0.261 0.123 DBMET02568 0.298 0.089 DBMET02569 0.258 0.127 DBMET02570 | DBMET02569 | |
| 0.164 | 0.014 | 0.164 | Dopamine D3 antagonist | 0.064 0.042 DBMET00341 0.092 0.027 DBMET02568 0.103 0.024 DBMET02569 | ||
| 0.174 | 0.024 | 0.203 | Chemokine receptor antagonist | 0.15 0.032 DBMET00341 0.203 0.018 DBMET02568 0.158 0.029 DBMET02569 0.137 0.038 DBMET02570 | DBMET02568 | |
| 0.153 | 0.004 | 0.21 | Sphingosine kinase inhibitor | 0.108 0.006 DBMET00341 0.147 0.004 DBMET02568 0.21 0.003 DBMET02569 0.143 0.004 DBMET02570 | DBMET02569 | |
| 0.159 | 0.01 | 0.159 | 5 Hydroxytryptamine 1A agonist | 0.054 0.027 DBMET00341 0.045 0.033 DBMET02568 0.058 0.025 DBMET02569 | ||
| 0.159 | 0.012 | 0.16 | 5 Hydroxytryptamine 1B antagonist | 0.089 0.029 DBMET00341 0.16 0.012 DBMET02568 0.069 0.041 DBMET02569 | DBMET02568 | |
| 0.147 | 0.008 | 0.147 | Viral attachment inhibitor | 0.145 0.009 DBMET00341 0.112 0.017 DBMET02568 0.118 0.015 DBMET02569 0.113 0.017 DBMET02570 | ||
| 0.166 | 0.028 | 0.166 | Antihistaminic | 0.157 0.03 DBMET02568 0.12 0.043 DBMET02569 | ||
| 0.174 | 0.037 | 0.22 | 5 Hydroxytryptamine 2 antagonist | 0.22 0.026 DBMET02568 0.136 0.05 DBMET02569 | DBMET02568 | |
| 0.175 | 0.041 | 0.224 | 5 Hydroxytryptamine antagonist | 0.103 0.076 DBMET00341 0.224 0.029 DBMET02568 0.114 0.068 DBMET02569 | DBMET02568 | |
| 0.156 | 0.023 | 0.156 | Histamine H1 receptor antagonist | 0.142 0.026 DBMET02568 0.135 0.028 DBMET02569 | ||
| 0.233 | 0.1 | 0.382 | 5 Hydroxytryptamine uptake stimulant | 0.382 0.018 DBMET00341 0.262 0.069 DBMET02568 0.248 0.083 DBMET02570 | DBMET00341 | |
| 0.157 | 0.028 | 0.157 | Histamine antagonist | 0.149 0.03 DBMET02568 0.11 0.043 DBMET02569 | ||
| 0.152 | 0.025 | 0.152 | Dopamine antagonist | 0.115 0.033 DBMET02568 0.112 0.034 DBMET02569 | ||
| 0.127 | 0.004 | 0.179 | Sphingosine kinase 1 inhibitor | 0.082 0.005 DBMET00341 0.122 0.004 DBMET02568 0.179 0.003 DBMET02569 0.12 0.004 DBMET02570 | DBMET02569 | |
| 0.153 | 0.032 | 0.155 | Nav1.1 sodium channel blocker | 0.115 0.052 DBMET02568 0.155 0.031 DBMET02569 | DBMET02569 | |
| 0.126 | 0.005 | 0.126 | CC chemokine 5 receptor antagonist | 0.088 0.011 DBMET00341 0.09 0.01 DBMET02568 0.092 0.01 DBMET02569 0.062 0.024 DBMET02570 | ||
| 0.175 | 0.055 | 0.205 | Acetylcholine M1 receptor antagonist | 0.137 0.088 DBMET00341 0.205 0.04 DBMET02568 0.158 0.067 DBMET02569 0.122 0.106 DBMET02570 | DBMET02568 | |
| 0.135 | 0.026 | 0.135 | 5 Hydroxytryptamine 1 antagonist | 0.063 0.06 DBMET00341 0.107 0.035 DBMET02568 | ||
| 0.114 | 0.005 | 0.139 | Potassium channel (Inward rectifier) blocker | 0.139 0.005 DBMET02568 0.094 0.008 DBMET02569 | DBMET02568 | |
| 0.127 | 0.024 | 0.16 | CC chemokine receptor antagonist | 0.085 0.047 DBMET00341 0.16 0.016 DBMET02568 0.11 0.03 DBMET02569 0.076 0.055 DBMET02570 | DBMET02568 | |
| 0.15 | 0.054 | 0.15 | Nav1.6 sodium channel blocker | 0.122 0.093 DBMET00341 0.141 0.065 DBMET02568 | ||
| 0.122 | 0.027 | 0.193 | 5 Hydroxytryptamine agonist | 0.193 0.015 DBMET00341 0.081 0.041 DBMET02568 0.082 0.041 DBMET02570 | DBMET00341 | |
| 0.224 | 0.132 | 0.426 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.426 0.016 DBMET02568 | DBMET02568 | |
| 0.136 | 0.046 | 0.216 | Alpha 2b adrenoreceptor antagonist | 0.094 0.081 DBMET00341 0.216 0.02 DBMET02568 | DBMET02568 | |
| 0.279 | 0.189 | 0.327 | 5 Hydroxytryptamine release inhibitor | 0.323 0.141 DBMET00341 0.327 0.137 DBMET02568 0.272 0.199 DBMET02569 0.315 0.149 DBMET02570 | DBMET02568 | |
| 0.098 | 0.008 | 0.178 | Sphingosine kinase 2 inhibitor | 0.052 0.043 DBMET00341 0.178 0.003 DBMET02568 0.118 0.005 DBMET02569 0.065 0.026 DBMET02570 | DBMET02568 | |
| 0.124 | 0.036 | 0.124 | 5 Hydroxytryptamine 2A antagonist | 0.119 0.038 DBMET02568 0.094 0.05 DBMET02569 | ||
| 0.112 | 0.025 | 0.119 | Histamine H2 receptor antagonist | 0.078 0.069 DBMET00341 0.119 0.021 DBMET02568 0.078 0.071 DBMET02569 | DBMET02568 | |
| 0.147 | 0.065 | 0.221 | Toll-Like receptor 9 antagonist | 0.221 0.027 DBMET00341 0.168 0.052 DBMET02568 0.145 0.066 DBMET02570 | DBMET00341 | |
| 0.101 | 0.019 | 0.197 | Adrenaline uptake inhibitor | 0.197 0.006 DBMET00341 0.071 0.034 DBMET02569 0.14 0.01 DBMET02570 | DBMET00341 | |
| 0.12 | 0.038 | 0.144 | Prolactin inhibitor | 0.144 0.025 DBMET00341 0.125 0.035 DBMET02568 0.098 0.058 DBMET02570 | DBMET00341 | |
| 0.109 | 0.03 | 0.109 | Dopamine D2 antagonist | 0.102 0.032 DBMET02568 0.072 0.043 DBMET02569 | ||
| 0.106 | 0.03 | 0.106 | 5 Hydroxytryptamine 1A antagonist | 0.083 0.039 DBMET02568 | ||
| 0.099 | 0.023 | 0.138 | 5 Hydroxytryptamine 1D antagonist | 0.138 0.014 DBMET02568 | DBMET02568 | |
| 0.18 | 0.106 | 0.232 | 5 Hydroxytryptamine 3E antagonist | 0.187 0.088 DBMET00341 0.232 0.026 DBMET02568 0.164 0.157 DBMET02570 | DBMET02568 | |
| 0.08 | 0.008 | 0.089 | Substance P antagonist | 0.089 0.006 DBMET00341 0.053 0.015 DBMET02569 0.055 0.014 DBMET02570 | DBMET00341 | |
| 0.137 | 0.065 | 0.245 | Toll-Like receptor antagonist | 0.206 0.028 DBMET00341 0.129 0.073 DBMET02568 0.172 0.042 DBMET02569 0.245 0.017 DBMET02570 | DBMET02570 | |
| 0.129 | 0.058 | 0.138 | Sphingosine 1-phosphate receptor 4 antagonist | 0.138 0.046 DBMET00341 0.117 0.079 DBMET02569 0.125 0.064 DBMET02570 | DBMET00341 | |
| 0.118 | 0.048 | 0.157 | Alpha adrenoreceptor antagonist | 0.157 0.036 DBMET02568 | DBMET02568 | |
| 0.075 | 0.006 | 0.077 | Sigma 2 receptor antagonist | 0.077 0.005 DBMET02568 0.045 0.011 DBMET02569 | DBMET02568 | |
| 0.095 | 0.027 | 0.095 | Calcium channel L-type blocker | 0.086 0.034 DBMET02568 0.09 0.03 DBMET02569 | ||
| 0.194 | 0.127 | 0.305 | Interleukin agonist | 0.277 0.061 DBMET00341 0.189 0.131 DBMET02568 0.225 0.098 DBMET02569 0.305 0.046 DBMET02570 | DBMET02570 | |
| 0.168 | 0.101 | 0.26 | Psychostimulant | 0.186 0.089 DBMET00341 0.26 0.055 DBMET02568 0.159 0.108 DBMET02569 0.177 0.095 DBMET02570 | DBMET02568 | |
| 0.102 | 0.036 | 0.181 | Adrenaline agonist | 0.087 0.049 DBMET00341 0.181 0.009 DBMET02568 0.16 0.012 DBMET02569 0.14 0.017 DBMET02570 | DBMET02568 | |
| 0.085 | 0.021 | 0.211 | 5 Hydroxytryptamine 5A antagonist | 0.058 0.048 DBMET00341 0.211 0.005 DBMET02568 0.064 0.039 DBMET02569 | DBMET02568 | |
| 0.08 | 0.016 | 0.08 | Histamine H3 receptor antagonist | 0.056 0.023 DBMET02568 0.038 0.036 DBMET02569 | ||
| 0.08 | 0.017 | 0.08 | Neurokinin antagonist | 0.065 0.023 DBMET00341 0.057 0.027 DBMET02569 0.048 0.037 DBMET02570 | ||
| 0.07 | 0.008 | 0.107 | Sigma 1 receptor antagonist | 0.107 0.006 DBMET02568 0.035 0.014 DBMET02569 | DBMET02568 | |
| 0.129 | 0.069 | 0.343 | Alpha-N-acetylglucosaminidase inhibitor | 0.235 0.025 DBMET00341 0.154 0.053 DBMET02568 0.193 0.036 DBMET02569 0.343 0.012 DBMET02570 | DBMET02570 | |
| 0.138 | 0.082 | 0.141 | Ca2+-transporting ATPase inhibitor | 0.141 0.07 DBMET00341 0.137 0.085 DBMET02568 0.135 0.093 DBMET02569 0.138 0.081 DBMET02570 | DBMET00341 | |
| 0.106 | 0.05 | 0.147 | Nitric-oxide synthase inhibitor | 0.122 0.037 DBMET00341 0.147 0.024 DBMET02568 0.091 0.076 DBMET02570 | DBMET02568 | |
| 0.112 | 0.059 | 0.188 | Ferrochelatase inhibitor | 0.188 0.025 DBMET00341 0.088 0.085 DBMET02568 0.103 0.067 DBMET02570 | DBMET00341 | |
| 0.075 | 0.025 | 0.075 | Calcium channel T-type blocker | 0.066 0.031 DBMET02568 | ||
| 0.147 | 0.098 | 0.204 | Antipruritic | 0.204 0.046 DBMET02568 0.164 0.079 DBMET02569 | DBMET02568 | |
| 0.115 | 0.066 | 0.302 | 5 Hydroxytryptamine 2B antagonist | 0.302 0.014 DBMET02568 | DBMET02568 | |
| 0.101 | 0.055 | 0.163 | Antiadrenergic | 0.163 0.032 DBMET02568 0.104 0.054 DBMET02569 | DBMET02568 | |
| 0.062 | 0.017 | 0.062 | Opioid kappa receptor agonist | 0.047 0.026 DBMET02569 | ||
| 0.07 | 0.026 | 0.19 | 5 Hydroxytryptamine 5 antagonist | 0.19 0.005 DBMET02568 0.053 0.05 DBMET02569 | DBMET02568 | |
| 0.098 | 0.055 | 0.16 | Adrenaline antagonist | 0.16 0.032 DBMET02568 0.101 0.053 DBMET02569 | DBMET02568 | |
| 0.248 | 0.207 | 0.367 | Calcium channel L-type activator | 0.328 0.134 DBMET00341 0.313 0.146 DBMET02568 0.297 0.16 DBMET02569 0.367 0.105 DBMET02570 | DBMET02570 | |
| 0.07 | 0.031 | 0.097 | Acetylcholine M5 receptor antagonist | 0.097 0.018 DBMET02568 0.061 0.041 DBMET02569 | DBMET02568 | |
| 0.077 | 0.039 | 0.09 | Phospholipase D inhibitor | 0.09 0.022 DBMET00341 0.079 0.036 DBMET02568 0.067 0.06 DBMET02570 | DBMET00341 | |
| 0.268 | 0.231 | 0.362 | Caspase 9 stimulant | 0.362 0.136 DBMET02568 | DBMET02568 | |
| 0.072 | 0.036 | 0.217 | 5 Hydroxytryptamine 7 antagonist | 0.217 0.011 DBMET02568 | DBMET02568 | |
| 0.151 | 0.116 | 0.393 | DNA methylase inhibitor | 0.138 0.129 DBMET00341 0.393 0.011 DBMET02568 0.16 0.109 DBMET02569 0.146 0.121 DBMET02570 | DBMET02568 | |
| 0.052 | 0.018 | 0.06 | Neurokinin 1 antagonist | 0.06 0.015 DBMET00341 0.041 0.027 DBMET02569 0.045 0.023 DBMET02570 | DBMET00341 | |
| 0.062 | 0.029 | 0.131 | Melanin-concentrating hormone receptor 1 antagonist | 0.131 0.008 DBMET02568 | DBMET02568 | |
| 0.069 | 0.037 | 0.076 | Dopamine D4 antagonist | 0.076 0.034 DBMET02568 | DBMET02568 | |
| 0.114 | 0.083 | 0.127 | Cathepsin H inhibitor | 0.118 0.077 DBMET00341 0.127 0.067 DBMET02568 | DBMET02568 | |
| 0.059 | 0.029 | 0.096 | Histamine agonist | 0.062 0.026 DBMET00341 0.096 0.01 DBMET02568 | DBMET02568 | |
| 0.039 | 0.01 | 0.07 | Melatonin antagonist | 0.07 0.005 DBMET00341 | DBMET00341 | |
| 0.053 | 0.026 | 0.053 | Potassium channel Kv1.3 blocker | |||
| 0.065 | 0.041 | 0.101 | 5 Hydroxytryptamine 2A agonist | 0.101 0.014 DBMET00341 | DBMET00341 | |
| 0.075 | 0.052 | 0.092 | Acetylcholine M4 receptor antagonist | 0.068 0.059 DBMET00341 0.092 0.035 DBMET02568 | DBMET02568 | |
| 0.042 | 0.02 | 0.042 | Nociceptin (N/OFQ) receptor antagonist | 0.031 0.028 DBMET00341 | ||
| 0.062 | 0.04 | 0.075 | Beta 2 adrenoreceptor agonist | 0.075 0.013 DBMET02568 0.072 0.016 DBMET02569 0.062 0.04 DBMET02570 | DBMET02568 | |
| 0.053 | 0.032 | 0.057 | 5 Hydroxytryptamine 4 antagonist | 0.057 0.028 DBMET02568 | DBMET02568 | |
| 0.07 | 0.049 | 0.1 | CXC chemokine receptor antagonist | 0.1 0.025 DBMET00341 0.091 0.029 DBMET02568 0.072 0.046 DBMET02569 0.099 0.025 DBMET02570 | DBMET00341 | |
| 0.058 | 0.038 | 0.058 | Potassium channel Kv1.5 blocker | |||
| 0.025 | 0.005 | 0.029 | CXC chemokine 5 receptor antagonist | 0.029 0.004 DBMET02568 0.019 0.009 DBMET02569 | DBMET02568 | |
| 0.035 | 0.015 | 0.062 | Epoxide hydrolase 1 inhibitor | 0.062 0.004 DBMET00341 0.036 0.014 DBMET02568 0.034 0.017 DBMET02570 | DBMET00341 | |
| 0.025 | 0.005 | 0.031 | Histone-lysine N-methyltransferase EZH2 inhibitor | 0.031 0.004 DBMET00341 0.022 0.008 DBMET02569 0.027 0.004 DBMET02570 | DBMET00341 | |
| 0.091 | 0.071 | 0.091 | Sphingomyelinase inhibitor | 0.085 0.079 DBMET02569 | ||
| 0.046 | 0.027 | 0.058 | Beta adrenoreceptor agonist | 0.057 0.01 DBMET02568 0.058 0.009 DBMET02569 0.051 0.016 DBMET02570 | DBMET02569 | |
| 0.076 | 0.058 | 0.087 | Interferon agonist | 0.079 0.053 DBMET02568 0.087 0.042 DBMET02569 | DBMET02569 | |
| 0.093 | 0.076 | 0.1 | Glutamate (mGluR7) agonist | 0.1 0.06 DBMET00341 0.097 0.066 DBMET02568 0.09 0.083 DBMET02570 | DBMET00341 | |
| 0.063 | 0.046 | 0.071 | Interferon inducer | 0.066 0.041 DBMET02568 0.071 0.033 DBMET02569 | DBMET02569 | |
| 0.141 | 0.125 | 0.163 | Neurotensin receptor agonist | 0.163 0.074 DBMET00341 0.144 0.116 DBMET02570 | DBMET00341 | |
| 0.056 | 0.039 | 0.067 | 5 Hydroxytryptamine 7 agonist | 0.059 0.032 DBMET00341 0.067 0.022 DBMET02568 | DBMET02568 | |
| 0.074 | 0.057 | 0.115 | Nicotinic alpha4beta2 receptor antagonist | 0.084 0.046 DBMET00341 0.115 0.021 DBMET02568 0.067 0.066 DBMET02570 | DBMET02568 | |
| 0.033 | 0.017 | 0.092 | 5 Hydroxytryptamine 1D agonist | 0.092 0.004 DBMET02568 | DBMET02568 | |
| 0.03 | 0.014 | 0.03 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.027 0.019 DBMET02568 | ||
| 0.024 | 0.009 | 0.042 | Melatonin 1 antagonist | 0.042 0.005 DBMET00341 | DBMET00341 | |
| 0.031 | 0.017 | 0.037 | Potassium channel (Inward rectifier) 1 blocker | 0.037 0.008 DBMET02568 0.032 0.017 DBMET02569 | DBMET02568 | |
| 0.044 | 0.03 | 0.054 | Histamine H1 receptor agonist | 0.054 0.014 DBMET00341 0.046 0.025 DBMET02568 | DBMET00341 | |
| 0.048 | 0.036 | 0.055 | Bombesin 2 receptor antagonist | 0.052 0.031 DBMET02568 0.055 0.028 DBMET02569 | DBMET02569 | |
| 0.125 | 0.113 | 0.125 | Growth hormone agonist | 0.125 0.113 DBMET02569 | ||
| 0.088 | 0.076 | 0.11 | Alpha 2d adrenoreceptor antagonist | 0.086 0.083 DBMET00341 0.11 0.034 DBMET02568 | DBMET02568 | |
| 0.055 | 0.044 | 0.057 | Cathepsin L inhibitor | 0.057 0.041 DBMET00341 0.053 0.047 DBMET02568 | DBMET00341 | |
| 0.034 | 0.022 | 0.046 | Melatonin 1 agonist | 0.046 0.011 DBMET00341 | DBMET00341 | |
| 0.035 | 0.024 | 0.035 | Adenosine uptake inhibitor | |||
| 0.091 | 0.08 | 0.092 | Falcipain 3 inhibitor | 0.092 0.078 DBMET02568 | DBMET02568 | |
| 0.031 | 0.021 | 0.031 | CXC chemokine 3 receptor antagonist | |||
| 0.051 | 0.041 | 0.068 | Nicotinic alpha3beta2 receptor antagonist | 0.059 0.027 DBMET00341 0.068 0.019 DBMET02568 0.049 0.047 DBMET02569 0.056 0.031 DBMET02570 | DBMET02568 | |
| 0.031 | 0.021 | 0.078 | Endothelial nitric-oxide synthase inhibitor | 0.032 0.02 DBMET00341 0.078 0.005 DBMET02568 | DBMET02568 | |
| 0.037 | 0.027 | 0.039 | Delayed rectifier potassium channel blocker | 0.039 0.022 DBMET02568 | DBMET02568 | |
| 0.031 | 0.025 | 0.04 | Melatonin agonist | 0.04 0.015 DBMET00341 | DBMET00341 | |
| 0.077 | 0.071 | 0.077 | Ca(v)3.1 blocker | 0.076 0.074 DBMET02568 | ||
| 0.052 | 0.047 | 0.052 | Sphingosine 1-phosphate receptor 1 antagonist | 0.052 0.049 DBMET02569 | ||
| 0.037 | 0.032 | 0.07 | Dopamine D5 agonist | 0.07 0.008 DBMET00341 0.059 0.012 DBMET02568 0.042 0.025 DBMET02570 | DBMET00341 | |
| 0.043 | 0.039 | 0.073 | Dopamine transporter inhibitor | 0.073 0.019 DBMET00341 0.046 0.036 DBMET02570 | DBMET00341 | |
| 0.098 | 0.094 | 0.099 | Cell adhesion inhibitor | 0.099 0.092 DBMET02569 | DBMET02569 | |
| 0.019 | 0.015 | 0.019 | Apolipoprotein B inhibitor | 0.019 0.015 DBMET02568 | ||
| 0.065 | 0.061 | 0.092 | Epoxide hydrolase inhibitor | 0.067 0.058 DBMET00341 0.092 0.031 DBMET02568 | DBMET02568 | |
| 0.037 | 0.033 | 0.064 | CC chemokine 3 receptor antagonist | 0.064 0.018 DBMET02568 | DBMET02568 | |
| 0.036 | 0.033 | 0.062 | GABA uptake inhibitor | 0.043 0.022 DBMET02568 0.062 0.009 DBMET02569 0.054 0.013 DBMET02570 | DBMET02569 | |
| 0.021 | 0.018 | 0.021 | Prostaglandin D2 antagonist | 0.02 0.019 DBMET02569 | ||
| 0.064 | 0.062 | 0.08 | Aminopeptidase I inhibitor | 0.067 0.058 DBMET02568 0.08 0.043 DBMET02569 0.078 0.045 DBMET02570 | DBMET02569 | |
| 0.035 | 0.033 | 0.035 | Dopamine D3 agonist | |||
| 0.102 | 0.1 | 0.184 | Transcription factor STAT6 inhibitor | 0.184 0.009 DBMET02568 | DBMET02568 | |
| 0.049 | 0.048 | 0.136 | CC chemokine 2 receptor antagonist | 0.136 0.007 DBMET02568 0.051 0.044 DBMET02569 | DBMET02568 | |
| 0.056 | 0.056 | 0.065 | Dopamine D1 antagonist | 0.065 0.045 DBMET02568 | DBMET02568 | |
| 0.05 | 0.052 | 0.065 | Fibroblast growth factor 4 antagonist | 0.063 0.035 DBMET00341 0.055 0.045 DBMET02569 0.065 0.031 DBMET02570 | DBMET02570 | |
| 0.195 | 0.198 | 0.306 | Interleukin 2 agonist | 0.232 0.14 DBMET00341 0.272 0.096 DBMET02569 0.306 0.069 DBMET02570 | DBMET02570 | |
| 0.021 | 0.024 | 0.022 | CC chemokine 8 receptor antagonist | 0.022 0.019 DBMET02568 | DBMET02568 | |
| 0.137 | 0.14 | 0.256 | Death-associated protein kinase 2 inhibitor | 0.191 0.042 DBMET00341 0.256 0.012 DBMET02568 0.143 0.124 DBMET02570 | DBMET02568 | |
| 0.07 | 0.076 | 0.089 | Ca(v)2.2 blocker | 0.089 0.057 DBMET00341 | DBMET00341 | |
| 0.117 | 0.125 | 0.132 | Thiol protease inhibitor | 0.132 0.092 DBMET00341 0.129 0.098 DBMET02568 0.126 0.104 DBMET02570 | DBMET00341 | |
| 0.027 | 0.035 | 0.146 | Leukotriene A4 hydrolase inhibitor | 0.146 0.005 DBMET02568 0.044 0.023 DBMET02569 | DBMET02568 | |
| 0.045 | 0.054 | 0.057 | 5 Hydroxytryptamine 1B agonist | 0.057 0.03 DBMET02568 | DBMET02568 | |
| 0.111 | 0.121 | 0.118 | Sphingosine 1-phosphate receptor 2 antagonist | 0.118 0.101 DBMET02568 | DBMET02568 | |
| 0.049 | 0.059 | 0.057 | Sphingosine 1-phosphate receptor 3 antagonist | 0.057 0.043 DBMET02568 | DBMET02568 | |
| 0.066 | 0.079 | 0.083 | Vanilloid 4 agonist | 0.083 0.036 DBMET00341 | DBMET00341 | |
| 0.117 | 0.133 | 0.138 | Sphingosine 1-phosphate receptor 5 antagonist | 0.138 0.083 DBMET02568 | DBMET02568 | |
| 0.013 | 0.029 | 0.019 | 5-Alpha-reductase 2 inhibitor | 0.019 0.013 DBMET00341 | DBMET00341 | |
| 0.066 | 0.084 | 0.114 | Glycine receptor antagonist | 0.114 0.022 DBMET00341 | DBMET00341 | |
| 0.033 | 0.051 | 0.064 | Chemokine receptor agonist | 0.064 0.024 DBMET02568 | DBMET02568 | |
| 0.059 | 0.077 | 0.163 | Alpha 2a adrenoreceptor antagonist | 0.163 0.02 DBMET02568 | DBMET02568 | |
| 0.021 | 0.039 | 0.026 | Acid ceramidase inhibitor | 0.026 0.018 DBMET00341 | DBMET00341 | |
| 0.089 | 0.108 | 0.12 | Nav1.5 sodium channel blocker | 0.12 0.055 DBMET02568 | DBMET02568 | |
| 0.056 | 0.075 | 0.059 | Prolactin release inhibitor | 0.059 0.055 DBMET00341 | DBMET00341 | |
| 0.045 | 0.065 | 0.063 | Epithelial sodium channel blocker | 0.055 0.037 DBMET00341 0.057 0.033 DBMET02568 0.052 0.044 DBMET02569 0.063 0.024 DBMET02570 | DBMET02570 | |
| 0.019 | 0.04 | 0.023 | 5 Hydroxytryptamine 4 agonist | 0.023 0.021 DBMET02568 | DBMET02568 | |
| 0.027 | 0.048 | 0.042 | Ceramide glucosyltransferase inhibitor | 0.042 0.015 DBMET02569 0.041 0.015 DBMET02570 | DBMET02569 | |
| 0.028 | 0.049 | 0.068 | Histone deacetylase 8 inhibitor | 0.068 0.013 DBMET02568 | DBMET02568 | |
| 0.043 | 0.065 | 0.093 | Alpha 1 adrenoreceptor agonist | 0.093 0.019 DBMET02568 | DBMET02568 | |
| 0.081 | 0.103 | 0.165 | 5 Hydroxytryptamine 3A agonist | 0.131 0.047 DBMET00341 0.165 0.028 DBMET02568 | DBMET02568 | |
| 0.191 | 0.214 | 0.35 | Toll-Like receptor agonist | 0.275 0.128 DBMET02568 0.35 0.082 DBMET02569 0.345 0.085 DBMET02570 | DBMET02569 | |
| 0.065 | 0.088 | 0.141 | Histamine N-methyltransferase inhibitor | 0.141 0.018 DBMET02568 | DBMET02568 | |
| 0.191 | 0.214 | 0.351 | Toll-Like receptor 7 agonist | 0.283 0.121 DBMET02568 0.351 0.081 DBMET02569 0.343 0.086 DBMET02570 | DBMET02569 | |
| 0.07 | 0.094 | 0.084 | Aminopeptidase B inhibitor | 0.082 0.08 DBMET02569 0.084 0.078 DBMET02570 | DBMET02570 | |
| 0.015 | 0.04 | 0.108 | Motilin receptor agonist | 0.026 0.012 DBMET00341 0.108 0.004 DBMET02568 | DBMET02568 | |
| 0.027 | 0.052 | 0.037 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.037 0.026 DBMET02569 | DBMET02569 | |
| 0.102 | 0.126 | 0.125 | Cytidine deaminase inhibitor | 0.125 0.096 DBMET00341 | DBMET00341 | |
| 0.05 | 0.075 | 0.056 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.056 0.054 DBMET02568 | DBMET02568 | |
| 0.032 | 0.058 | 0.039 | Plasmepsin II inhibitor | 0.039 0.033 DBMET00341 | DBMET00341 | |
| 0.118 | 0.145 | 0.16 | Amyloid beta precursor protein antagonist | 0.16 0.091 DBMET02569 0.136 0.119 DBMET02570 | DBMET02569 | |
| 0.075 | 0.104 | 0.338 | GABA C receptor agonist | 0.286 0.01 DBMET00341 0.146 0.035 DBMET02568 0.089 0.081 DBMET02569 0.338 0.007 DBMET02570 | DBMET02570 | |
| 0.072 | 0.102 | 0.09 | Creatine kinase inhibitor | 0.09 0.072 DBMET02570 | DBMET02570 | |
| 0.037 | 0.067 | 0.045 | Heme oxygenase inhibitor | 0.045 0.022 DBMET02568 | DBMET02568 | |
| 0.014 | 0.045 | 0.02 | Glutaminyl-peptide cyclotransferase inhibitor | 0.02 0.019 DBMET00341 | DBMET00341 | |
| 0.026 | 0.057 | 0.039 | Neurokinin 2 antagonist | 0.039 0.031 DBMET02568 | DBMET02568 | |
| 0.016 | 0.048 | 0.024 | Histamine H3 receptor agonist | 0.024 0.023 DBMET02568 | DBMET02568 | |
| 0.059 | 0.091 | 0.124 | 5 Hydroxytryptamine 2C antagonist | 0.124 0.035 DBMET02568 | DBMET02568 | |
| 0.108 | 0.14 | 0.134 | Hexokinase inhibitor | 0.134 0.099 DBMET02569 0.133 0.1 DBMET02570 | DBMET02569 | |
| 0.052 | 0.085 | 0.069 | Beta 3 adrenoreceptor antagonist | 0.061 0.054 DBMET00341 0.06 0.057 DBMET02569 0.069 0.035 DBMET02570 | DBMET02570 | |
| 0.012 | 0.046 | 0.028 | Imidazoline I1 receptor antagonist | 0.022 0.013 DBMET00341 0.028 0.008 DBMET02568 | DBMET02568 | |
| 0.057 | 0.093 | 0.088 | Glycine receptor agonist | 0.088 0.03 DBMET00341 0.072 0.051 DBMET02570 | DBMET00341 | |
| 0.055 | 0.094 | 0.073 | Calcium antagonist | 0.073 0.07 DBMET02568 | DBMET02568 | |
| 0.062 | 0.103 | 0.117 | Inducible nitric-oxide synthase inhibitor | 0.117 0.026 DBMET00341 0.081 0.06 DBMET02570 | DBMET00341 | |
| 0.05 | 0.091 | 0.074 | Potassium channel (ATP-sensitive) blocker | 0.074 0.035 DBMET02568 | DBMET02568 | |
| 0.064 | 0.109 | 0.081 | Caspase 7 inhibitor | 0.081 0.059 DBMET02568 | DBMET02568 | |
| 0.018 | 0.064 | 0.025 | Myristoyl transferase inhibitor | 0.025 0.023 DBMET00341 | DBMET00341 | |
| 0.034 | 0.08 | 0.042 | Dipeptidyl peptidase IV inhibitor | 0.042 0.035 DBMET02568 | DBMET02568 | |
| 0.025 | 0.071 | 0.044 | Adenosine deaminase inhibitor | 0.044 0.036 DBMET02568 0.043 0.037 DBMET02569 | DBMET02568 | |
| 0.033 | 0.079 | 0.059 | Acetylcholine muscarinic agonist | 0.059 0.035 DBMET00341 | DBMET00341 | |
| 0.047 | 0.093 | 0.059 | Protease 3C (Human rhinovirus) inhibitor | 0.059 0.054 DBMET00341 | DBMET00341 | |
| 0.072 | 0.119 | 0.202 | GABA C receptor rho-1 antagonist | 0.202 0.008 DBMET00341 0.096 0.068 DBMET02568 0.161 0.017 DBMET02570 | DBMET00341 | |
| 0.038 | 0.087 | 0.115 | Cyclin A2 inhibitor | 0.115 0.02 DBMET00341 0.063 0.044 DBMET02568 0.089 0.028 DBMET02570 | DBMET00341 | |
| 0.039 | 0.087 | 0.051 | Dipeptidyl peptidase inhibitor | 0.051 0.04 DBMET02568 | DBMET02568 | |
| 0.086 | 0.134 | 0.149 | Toll-Like receptor 2 antagonist | 0.149 0.053 DBMET00341 0.123 0.075 DBMET02570 | DBMET00341 | |
| 0.023 | 0.073 | 0.049 | Acetylcholine M1 receptor agonist | 0.049 0.026 DBMET00341 | DBMET00341 | |
| 0.038 | 0.089 | 0.056 | Fatty acid synthase inhibitor | 0.056 0.041 DBMET00341 | DBMET00341 | |
| 0.07 | 0.121 | 0.087 | Interleukin 1 beta converting enzyme inhibitor | 0.087 0.077 DBMET02568 | DBMET02568 | |
| 0.041 | 0.093 | 0.088 | Alpha 1 adrenoreceptor antagonist | 0.088 0.049 DBMET02568 | DBMET02568 | |
| 0.099 | 0.151 | 0.122 | Vanilloid 1 agonist | 0.122 0.082 DBMET02569 0.12 0.087 DBMET02570 | DBMET02569 | |
| 0.144 | 0.197 | 0.224 | Superoxide dismutase inhibitor | 0.214 0.103 DBMET00341 0.172 0.153 DBMET02568 0.224 0.094 DBMET02570 | DBMET02570 | |
| 0.023 | 0.078 | 0.058 | Somatostatin 4 agonist | 0.058 0.013 DBMET00341 | DBMET00341 | |
| 0.027 | 0.082 | 0.043 | Nicotinic receptor alpha3 subunit antagonist | 0.043 0.031 DBMET02568 | DBMET02568 | |
| 0.011 | 0.067 | 0.041 | Arginase inhibitor | 0.041 0.022 DBMET02570 | DBMET02570 | |
| 0.034 | 0.091 | 0.105 | Cyclin A inhibitor | 0.105 0.021 DBMET00341 0.055 0.048 DBMET02568 0.077 0.033 DBMET02570 | DBMET00341 | |
| 0.179 | 0.238 | 0.336 | GABA C receptor rho-3 antagonist | 0.336 0.094 DBMET00341 0.219 0.185 DBMET02568 | DBMET00341 | |
| 0.055 | 0.116 | 0.087 | Fibroblast growth factor 1 antagonist | 0.087 0.068 DBMET02568 | DBMET02568 | |
| 0.067 | 0.129 | 0.082 | Estrogen-related receptor beta agonist | 0.079 0.069 DBMET02569 0.082 0.061 DBMET02570 | DBMET02570 | |
| 0.119 | 0.182 | 0.182 | Succinate dehydrogenase inhibitor | 0.157 0.1 DBMET00341 0.145 0.123 DBMET02568 0.141 0.129 DBMET02569 0.182 0.066 DBMET02570 | DBMET02570 | |
| 0.01 | 0.073 | 0.035 | Sphingosine 1-phosphate receptor 3 agonist | 0.035 0.024 DBMET02569 | DBMET02569 | |
| 0.033 | 0.096 | 0.054 | Dopamine beta hydroxylase inhibitor | 0.054 0.023 DBMET02568 | DBMET02568 | |
| 0.033 | 0.097 | 0.068 | Alpha-mannosidase inhibitor | 0.052 0.04 DBMET00341 0.068 0.019 DBMET02570 | DBMET02570 | |
| 0.039 | 0.105 | 0.159 | Alpha adrenoreceptor agonist | 0.159 0.015 DBMET02568 | DBMET02568 | |
| 0.028 | 0.094 | 0.058 | CC chemokine 4 receptor antagonist | 0.058 0.018 DBMET02568 | DBMET02568 | |
| 0.048 | 0.114 | 0.058 | Histone deacetylase SIRT3 inhibitor | 0.058 0.057 DBMET00341 | DBMET00341 | |
| 0.032 | 0.098 | 0.055 | Histamine H4 receptor antagonist | 0.051 0.029 DBMET00341 0.055 0.024 DBMET02568 | DBMET02568 | |
| 0.034 | 0.102 | 0.085 | Alpha 1b adrenoreceptor antagonist | 0.085 0.043 DBMET02568 | DBMET02568 | |
| 0.071 | 0.14 | 0.221 | GABA C receptor antagonist | 0.221 0.009 DBMET00341 0.094 0.088 DBMET02568 0.173 0.02 DBMET02570 | DBMET00341 | |
| 0.004 | 0.073 | 0.013 | Integrin beta2 antagonist | 0.013 0.008 DBMET02568 | DBMET02568 | |
| 0.103 | 0.175 | 0.302 | DNA methyltransferase I inhibitor | 0.148 0.106 DBMET00341 0.302 0.026 DBMET02568 0.154 0.099 DBMET02570 | DBMET02568 | |
| 0.052 | 0.125 | 0.095 | Acetylcholine agonist | 0.095 0.051 DBMET00341 0.081 0.065 DBMET02568 | DBMET00341 | |
| 0.048 | 0.123 | 0.119 | Acetylcholine nicotinic agonist | 0.087 0.048 DBMET00341 0.119 0.027 DBMET02568 | DBMET02568 | |
| 0.06 | 0.137 | 0.085 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.085 0.072 DBMET02570 | DBMET02570 | |
| 0.07 | 0.15 | 0.115 | Toll-Like receptor 4 antagonist | 0.115 0.049 DBMET02569 0.099 0.071 DBMET02570 | DBMET02569 | |
| 0.027 | 0.108 | 0.068 | Alpha 1a adrenoreceptor antagonist | 0.068 0.052 DBMET02568 | DBMET02568 | |
| 0.121 | 0.202 | 0.477 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.15 0.134 DBMET00341 0.477 0.005 DBMET02568 | DBMET02568 | |
| 0.006 | 0.088 | 0.017 | Nicotinic alpha4 receptor agonist | 0.017 0.011 DBMET00341 | DBMET00341 | |
| 0.007 | 0.09 | 0.014 | Cyclin D2 inhibitor | 0.014 0.008 DBMET00341 0.013 0.011 DBMET02568 0.013 0.01 DBMET02570 | DBMET00341 | |
| 0.03 | 0.115 | 0.134 | NMDA 2 receptor antagonist | 0.134 0.02 DBMET02568 | DBMET02568 | |
| 0.021 | 0.107 | 0.063 | Mannosidase inhibitor | 0.044 0.034 DBMET00341 0.063 0.015 DBMET02570 | DBMET02570 | |
| 0.023 | 0.11 | 0.051 | Potassium channel Kv1.1 blocker | 0.051 0.012 DBMET02568 | DBMET02568 | |
| 0.106 | 0.193 | 0.159 | Anticonvulsant | 0.159 0.119 DBMET02568 | DBMET02568 | |
| 0.011 | 0.101 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.021 0.013 DBMET02568 | DBMET02568 | |
| 0.009 | 0.101 | 0.027 | Cyclin E2 inhibitor | 0.027 0.022 DBMET02568 | DBMET02568 | |
| 0.023 | 0.116 | 0.047 | Neuraminidase (Influenza A) inhibitor | 0.047 0.029 DBMET02570 | DBMET02570 | |
| 0.113 | 0.207 | 0.171 | Phospholipase C inhibitor | 0.171 0.071 DBMET00341 0.156 0.095 DBMET02570 | DBMET00341 | |
| 0.016 | 0.112 | 0.032 | Estrogen-related receptor gamma antagonist | 0.032 0.013 DBMET02570 | DBMET02570 | |
| 0.01 | 0.106 | 0.027 | Lysine carboxypeptidase inhibitor | 0.027 0.018 DBMET02570 | DBMET02570 | |
| 0.023 | 0.121 | 0.056 | Cannabinoid CB1 receptor agonist | 0.056 0.047 DBMET02568 | DBMET02568 | |
| 0.031 | 0.129 | 0.09 | Cyclin D1 inhibitor | 0.09 0.012 DBMET02568 | DBMET02568 | |
| 0.126 | 0.225 | 0.152 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.152 0.144 DBMET02568 | DBMET02568 | |
| 0.024 | 0.124 | 0.074 | Nicotinic neuronal receptor agonist | 0.05 0.045 DBMET00341 0.074 0.025 DBMET02568 | DBMET02568 | |
| 0.024 | 0.124 | 0.05 | Beta 2 adrenoreceptor antagonist | 0.05 0.036 DBMET02570 | DBMET02570 | |
| 0.059 | 0.159 | 0.146 | Polo-like kinase-1 inhibitor | 0.146 0.018 DBMET02568 | DBMET02568 | |
| 0.043 | 0.145 | 0.069 | Somatostatin 1 agonist | 0.069 0.066 DBMET00341 | DBMET00341 | |
| 0.057 | 0.159 | 0.108 | MAP kinase kinase 7 inhibitor | 0.087 0.03 DBMET00341 0.098 0.015 DBMET02568 0.076 0.06 DBMET02569 0.108 0.008 DBMET02570 | DBMET02570 | |
| 0.03 | 0.132 | 0.078 | 5 Hydroxytryptamine 3A antagonist | 0.078 0.033 DBMET02568 | DBMET02568 | |
| 0.029 | 0.132 | 0.121 | Alpha 2 adrenoreceptor agonist | 0.063 0.039 DBMET00341 0.121 0.01 DBMET02568 | DBMET02568 | |
| 0.009 | 0.112 | 0.035 | Nicotinic alpha4beta2 receptor agonist | 0.035 0.011 DBMET00341 0.03 0.017 DBMET02570 | DBMET00341 | |
| 0.143 | 0.247 | 0.321 | Immunomodulator | 0.195 0.17 DBMET00341 0.255 0.111 DBMET02569 0.321 0.071 DBMET02570 | DBMET02570 | |
| 0.026 | 0.132 | 0.074 | Carbamoyl phosphate synthetase inhibitor | 0.074 0.032 DBMET02570 | DBMET02570 | |
| 0.053 | 0.16 | 0.123 | Breast cancer-resistant protein inhibitor | 0.123 0.037 DBMET02568 | DBMET02568 | |
| 0.025 | 0.133 | 0.06 | Selectin antagonist | 0.06 0.049 DBMET02570 | DBMET02570 | |
| 0.094 | 0.202 | 0.14 | Adenylate cyclase stimulant | 0.14 0.081 DBMET00341 0.138 0.084 DBMET02570 | DBMET00341 | |
| 0.026 | 0.134 | 0.072 | Nicotinic alpha7 receptor agonist | 0.072 0.022 DBMET02568 | DBMET02568 | |
| 0.038 | 0.148 | 0.08 | Acetylcholine nicotinic antagonist | 0.08 0.054 DBMET02568 | DBMET02568 | |
| 0.025 | 0.135 | 0.11 | 5 Hydroxytryptamine 6 antagonist | 0.11 0.012 DBMET02568 | DBMET02568 | |
| 0.099 | 0.21 | 0.124 | Pregnane X receptor agonist | 0.124 0.118 DBMET00341 | DBMET00341 | |
| 0.017 | 0.133 | 0.026 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.021 DBMET02568 | DBMET02568 | |
| 0.03 | 0.148 | 0.101 | Bombesin 3 receptor antagonist | 0.101 0.012 DBMET02568 | DBMET02568 | |
| 0.145 | 0.263 | 0.202 | Insulysin inhibitor | 0.202 0.154 DBMET00341 0.186 0.179 DBMET02570 | DBMET00341 | |
| 0.053 | 0.17 | 0.102 | Triose-phosphate isomerase inhibitor | 0.102 0.045 DBMET02570 | DBMET02570 | |
| 0.052 | 0.17 | 0.109 | UDP-glucose 4-epimerase inhibitor | 0.109 0.052 DBMET02570 | DBMET02570 | |
| 0.022 | 0.14 | 0.055 | Alcohol oxidase inhibitor | 0.055 0.04 DBMET02570 | DBMET02570 | |
| 0.001 | 0.121 | 0.007 | CC chemokine 6 receptor agonist | 0.007 0.004 DBMET02568 | DBMET02568 | |
| 0.027 | 0.147 | 0.058 | Cannabinoid CB1 receptor antagonist | 0.058 0.047 DBMET02568 | DBMET02568 | |
| 0.032 | 0.154 | 0.096 | Glucosylceramidase inhibitor | 0.054 0.039 DBMET00341 0.051 0.047 DBMET02568 0.05 0.049 DBMET02569 0.096 0.009 DBMET02570 | DBMET02570 | |
| 0.132 | 0.255 | 0.243 | Peptidyltransferase inhibitor | 0.177 0.134 DBMET00341 0.199 0.1 DBMET02569 0.243 0.056 DBMET02570 | DBMET02570 | |
| 0.028 | 0.153 | 0.067 | Cannabinoid receptor antagonist | 0.067 0.053 DBMET02568 | DBMET02568 | |
| 0.026 | 0.158 | 0.067 | Neuronal nicotinic receptor antagonist | 0.067 0.047 DBMET02568 | DBMET02568 | |
| 0.034 | 0.17 | 0.058 | Corticotropin releasing factor 2 receptor antagonist | 0.058 0.05 DBMET00341 | DBMET00341 | |
| 0.049 | 0.185 | 0.082 | GABA B receptor agonist | 0.082 0.039 DBMET02570 | DBMET02570 | |
| 0.023 | 0.16 | 0.088 | Cyclin-dependent kinase 6 inhibitor | 0.067 0.034 DBMET00341 0.088 0.016 DBMET02568 0.058 0.043 DBMET02570 | DBMET02568 | |
| 0.03 | 0.175 | 0.067 | Beta adrenoreceptor antagonist | 0.067 0.043 DBMET02570 | DBMET02570 | |
| 0.019 | 0.169 | 0.058 | Cannabinoid receptor agonist | 0.058 0.05 DBMET02568 | DBMET02568 | |
| 0.02 | 0.171 | 0.037 | Thymidine kinase inhibitor | 0.037 0.035 DBMET02568 | DBMET02568 | |
| 0.058 | 0.21 | 0.086 | Toll-Like receptor 3 antagonist | 0.086 0.079 DBMET02568 | DBMET02568 | |
| 0.013 | 0.166 | 0.051 | Ornithine carbamoyltransferase inhibitor | 0.051 0.039 DBMET02570 | DBMET02570 | |
| 0.086 | 0.24 | 0.157 | Aldehyde oxidase inhibitor | 0.157 0.132 DBMET02568 | DBMET02568 | |
| 0.012 | 0.168 | 0.031 | CDK6/cyclin D3 inhibitor | 0.031 0.03 DBMET02568 | DBMET02568 | |
| 0.013 | 0.169 | 0.048 | Cannabinoid CB2 receptor agonist | 0.048 0.044 DBMET02568 | DBMET02568 | |
| 0.02 | 0.18 | 0.055 | Nicotinic receptor alpha7 subunit antagonist | 0.055 0.034 DBMET02568 | DBMET02568 | |
| 0.011 | 0.173 | 0.049 | CDK4/cyclin D3 inhibitor | 0.049 0.007 DBMET02568 | DBMET02568 | |
| 0.064 | 0.227 | 0.116 | CDK3/cyclin E inhibitor | 0.116 0.061 DBMET00341 | DBMET00341 | |
| 0.027 | 0.192 | 0.074 | Rho-associated kinase I inhibitor | 0.074 0.052 DBMET02568 | DBMET02568 | |
| 0.019 | 0.185 | 0.062 | Cyclin A1 inhibitor | 0.061 0.036 DBMET00341 0.062 0.034 DBMET02568 | DBMET02568 | |
| 0.076 | 0.243 | 0.134 | Heat shock protein 90 alpha antagonist | 0.134 0.105 DBMET02568 | DBMET02568 | |
| 0.01 | 0.178 | 0.04 | MAP3K8 inhibitor | 0.04 0.007 DBMET02568 | DBMET02568 | |
| 0.049 | 0.217 | 0.105 | DNA polymerase I inhibitor | 0.105 0.081 DBMET02569 | DBMET02569 | |
| 0.09 | 0.265 | 0.129 | Death-associated protein kinase 1 inhibitor | 0.129 0.084 DBMET00341 | DBMET00341 | |
| 0.026 | 0.2 | 0.063 | Cyclin H inhibitor | 0.063 0.035 DBMET02568 | DBMET02568 | |
| 0.043 | 0.219 | 0.186 | Insulin receptor antagonist | 0.186 0.017 DBMET02568 | DBMET02568 | |
| 0.118 | 0.297 | 0.182 | RNA-directed DNA polymerase inhibitor | 0.182 0.129 DBMET00341 0.17 0.153 DBMET02570 | DBMET00341 | |
| 0.156 | 0.336 | 0.321 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.238 0.082 DBMET00341 0.321 0.017 DBMET02568 0.212 0.134 DBMET02570 | DBMET02568 | |
| 0.006 | 0.187 | 0.033 | Nicotinic alpha3beta4 receptor agonist | 0.033 0.016 DBMET00341 | DBMET00341 | |
| 0.121 | 0.302 | 0.159 | MAP kinase kinase 5 inhibitor | 0.159 0.118 DBMET00341 0.159 0.118 DBMET02568 0.159 0.118 DBMET02570 | DBMET02570 | |
| 0.119 | 0.302 | 0.24 | Vasodilator, peripheral | 0.194 0.183 DBMET00341 0.24 0.135 DBMET02568 | DBMET02568 | |
| 0.077 | 0.263 | 0.154 | GABA C receptor rho-2 antagonist | 0.154 0.068 DBMET00341 | DBMET00341 | |
| 0.062 | 0.25 | 0.177 | Interleukin 8 antagonist | 0.177 0.02 DBMET02568 | DBMET02568 | |
| 0.117 | 0.307 | 0.192 | Nootropic | 0.192 0.169 DBMET02568 | DBMET02568 | |
| 0.024 | 0.216 | 0.057 | Protein kinase C iota inhibitor | 0.057 0.043 DBMET02568 | DBMET02568 | |
| 0.031 | 0.229 | 0.073 | Bcl2 antagonist | 0.073 0.038 DBMET02568 | DBMET02568 | |
| 0.039 | 0.237 | 0.253 | EphA2 antagonist | 0.253 0.006 DBMET02568 | DBMET02568 | |
| 0.136 | 0.336 | 0.253 | Calcium channel activator | 0.253 0.144 DBMET02568 | DBMET02568 | |
| 0.017 | 0.216 | 0.048 | Phenylethanolamine N methyltransferase inhibitor | 0.048 0.017 DBMET00341 0.048 0.016 DBMET02570 | DBMET02570 | |
| 0.103 | 0.303 | 0.22 | Calpain 2 inhibitor | 0.22 0.171 DBMET02568 | DBMET02568 | |
| 0.021 | 0.223 | 0.071 | Lysine-specific demethylase 1A inhibitor | 0.05 0.046 DBMET00341 0.071 0.017 DBMET02568 | DBMET02568 | |
| 0.014 | 0.222 | 0.036 | Integrin alpha2 antagonist | 0.036 0.027 DBMET02570 | DBMET02570 | |
| 0.019 | 0.231 | 0.068 | NMDA 2B receptor antagonist | 0.068 0.026 DBMET02568 | DBMET02568 | |
| 0.057 | 0.27 | 0.112 | Peroxidase inhibitor | 0.112 0.109 DBMET02570 | DBMET02570 | |
| 0.072 | 0.295 | 0.228 | Platelet aggregation inhibitor | 0.228 0.063 DBMET02568 | DBMET02568 | |
| 0.067 | 0.296 | 0.156 | Immunostimulant | 0.156 0.15 DBMET02570 | DBMET02570 | |
| 0.015 | 0.244 | 0.035 | Protein kinase (CK2) beta inhibitor | 0.035 0.019 DBMET02568 0.031 0.028 DBMET02570 | DBMET02568 | |
| 0.014 | 0.251 | 0.094 | CDK4/cyclin D inhibitor | 0.094 0.016 DBMET02568 | DBMET02568 | |
| 0.014 | 0.261 | 0.089 | CDK4/cyclin D1 inhibitor | 0.089 0.019 DBMET02568 | DBMET02568 | |
| 0.016 | 0.263 | 0.042 | CDK7/cyclin H inhibitor | 0.042 0.039 DBMET02568 | DBMET02568 | |
| 0.027 | 0.275 | 0.103 | Platelet activating factor antagonist | 0.103 0.076 DBMET02568 | DBMET02568 | |
| 0.071 | 0.319 | 0.168 | Tumour necrosis factor alpha release inhibitor | 0.168 0.136 DBMET02568 | DBMET02568 | |
| 0.005 | 0.259 | 0.087 | Janus tyrosine kinase 1 inhibitor | 0.087 0.027 DBMET02568 | DBMET02568 | |
| 0.035 | 0.289 | 0.113 | Protein kinase C gamma inhibitor | 0.095 0.087 DBMET00341 0.104 0.07 DBMET02568 0.113 0.059 DBMET02570 | DBMET02570 | |
| 0.031 | 0.29 | 0.073 | Carbonic anhydrase VI inhibitor | 0.073 0.068 DBMET02568 | DBMET02568 | |
| 0.021 | 0.283 | 0.066 | MAP kinase kinase 9 inhibitor | 0.066 0.024 DBMET02568 | DBMET02568 | |
| 0.019 | 0.282 | 0.04 | DNA gyrase subunit A inhibitor | 0.04 0.034 DBMET02570 | DBMET02570 | |
| 0.025 | 0.29 | 0.078 | Polo-like kinase-2 inhibitor | 0.078 0.046 DBMET02568 | DBMET02568 | |
| 0.016 | 0.284 | 0.078 | Protein kinase C beta inhibitor | 0.071 0.045 DBMET02568 0.078 0.033 DBMET02570 | DBMET02570 | |
| 0.048 | 0.322 | 0.13 | Protein kinase stimulant | 0.13 0.083 DBMET02570 | DBMET02570 | |
| 0.017 | 0.296 | 0.065 | CDK2/cyclin E2 inhibitor | 0.065 0.055 DBMET02568 | DBMET02568 | |
| 0.022 | 0.307 | 0.088 | CDK2/cyclin A inhibitor | 0.088 0.07 DBMET02568 | DBMET02568 | |
| 0.049 | 0.336 | 0.12 | Heat shock protein 90 antagonist | 0.12 0.114 DBMET02568 | DBMET02568 | |
| 0.067 | 0.356 | 0.15 | CF transmembrane conductance regulator agonist | 0.15 0.076 DBMET02568 | DBMET02568 | |
| 0.105 | 0.397 | 0.211 | ErbB-1 antagonist | 0.211 0.078 DBMET02568 | DBMET02568 | |
| 0.013 | 0.31 | 0.089 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.089 0.058 DBMET02568 | DBMET02568 | |
| 0.021 | 0.319 | 0.123 | CDK/cyclin complex inhibitor | 0.123 0.04 DBMET02568 | DBMET02568 | |
| 0.019 | 0.317 | 0.085 | Bcr-Abl kinase inhibitor | 0.085 0.058 DBMET02568 | DBMET02568 | |
| 0.018 | 0.318 | 0.088 | Insulin like growth factor 1 antagonist | 0.088 0.051 DBMET02568 | DBMET02568 | |
| 0.008 | 0.313 | 0.031 | Protein kinase C beta II inhibitor | 0.031 0.027 DBMET02570 | DBMET02570 | |
| 0.016 | 0.32 | 0.073 | Cyclin-dependent kinase 4 inhibitor | 0.073 0.039 DBMET02568 | DBMET02568 | |
| 0.017 | 0.329 | 0.092 | Insulin growth factor antagonist | 0.092 0.053 DBMET02568 | DBMET02568 | |
| 0.014 | 0.334 | 0.067 | Myc inhibitor | 0.067 0.021 DBMET00341 0.066 0.022 DBMET02570 | DBMET00341 | |
| 0.008 | 0.328 | 0.045 | Neuropeptide Y5 antagonist | 0.045 0.043 DBMET02568 | DBMET02568 | |
| 0.072 | 0.397 | 0.228 | DNA synthesis inhibitor | 0.186 0.145 DBMET00341 0.228 0.085 DBMET02570 | DBMET02570 | |
| 0.012 | 0.338 | 0.066 | Syk tyrosine kinase inhibitor | 0.066 0.054 DBMET02568 | DBMET02568 | |
| 0.005 | 0.336 | 0.075 | CDK2/cyclin E inhibitor | 0.075 0.032 DBMET02568 | DBMET02568 | |
| 0.06 | 0.391 | 0.153 | MAP kinase 3 inhibitor | 0.153 0.062 DBMET02568 | DBMET02568 | |
| 0.02 | 0.352 | 0.095 | Protein kinase C zeta inhibitor | 0.091 0.063 DBMET02568 0.095 0.057 DBMET02570 | DBMET02570 | |
| 0.007 | 0.34 | 0.076 | CDK1/cyclin B inhibitor | 0.076 0.036 DBMET02568 | DBMET02568 | |
| 0.044 | 0.403 | 0.121 | Aurora-C kinase inhibitor | 0.121 0.104 DBMET00341 | DBMET00341 | |
| 0.017 | 0.381 | 0.086 | Focal adhesion kinase 1 inhibitor | 0.086 0.043 DBMET02568 | DBMET02568 | |
| 0.01 | 0.382 | 0.148 | Protein kinase (CK2) alpha inhibitor | 0.148 0.043 DBMET02568 | DBMET02568 | |
| 0.01 | 0.385 | 0.13 | Protein kinase (CK2) inhibitor | 0.13 0.043 DBMET02568 | DBMET02568 | |
| 0.013 | 0.396 | 0.082 | Rho-associated kinase inhibitor | 0.082 0.044 DBMET02568 | DBMET02568 | |
| 0.01 | 0.402 | 0.037 | Estrogen-related receptor beta antagonist | 0.032 0.023 DBMET02569 0.037 0.014 DBMET02570 | DBMET02570 | |
| 0.012 | 0.414 | 0.12 | Platelet activating factor alpha antagonist | 0.12 0.045 DBMET02568 | DBMET02568 | |
| 0.084 | 0.488 | 0.149 | CC chemokine 6 receptor antagonist | 0.149 0.023 DBMET02568 | DBMET02568 | |
| 0.008 | 0.413 | 0.061 | Phosphodiesterase 4B inhibitor | 0.061 0.054 DBMET02568 | DBMET02568 | |
| 0.023 | 0.439 | 0.145 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.145 0.092 DBMET02568 | DBMET02568 | |
| 0.038 | 0.459 | 0.218 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.218 0.065 DBMET02568 | DBMET02568 | |
| 0.011 | 0.437 | 0.094 | MAP kinase kinase kinase inhibitor | 0.094 0.072 DBMET02568 | DBMET02568 | |
| 0.018 | 0.451 | 0.132 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.132 0.076 DBMET02568 | DBMET02568 | |
| 0.027 | 0.479 | 0.112 | MAP kinase kinase 8 inhibitor | 0.112 0.017 DBMET02568 | DBMET02568 | |
| 0.015 | 0.469 | 0.143 | Vascular endothelial growth factor 1 antagonist | 0.143 0.044 DBMET02568 | DBMET02568 | |
| 0.009 | 0.464 | 0.052 | Protein kinase C theta inhibitor | 0.052 0.049 DBMET02568 | DBMET02568 | |
| 0.017 | 0.474 | 0.078 | AXL receptor tyrosine kinase inhibitor | 0.078 0.065 DBMET02568 | DBMET02568 | |
| 0.025 | 0.483 | 0.158 | Tyrosine kinase inhibitor | 0.158 0.085 DBMET02568 | DBMET02568 | |
| 0.019 | 0.481 | 0.148 | Ephrin antagonist | 0.148 0.037 DBMET02568 | DBMET02568 | |
| 0.019 | 0.487 | 0.119 | Epidermal growth factor receptor kinase inhibitor | 0.119 0.074 DBMET02568 | DBMET02568 | |
| 0.02 | 0.492 | 0.144 | MAP kinase kinase 2 inhibitor | 0.144 0.127 DBMET02568 | DBMET02568 | |
| 0.02 | 0.495 | 0.152 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.152 0.06 DBMET02568 | DBMET02568 | |
| 0.017 | 0.497 | 0.163 | Src kinase inhibitor | 0.163 0.075 DBMET02568 | DBMET02568 | |
| 0.092 | 0.575 | 0.411 | MAP kinase kinase 6 inhibitor | 0.411 0.052 DBMET02568 | DBMET02568 | |
| 0.015 | 0.498 | 0.084 | Protein kinase C mu inhibitor | 0.084 0.075 DBMET02568 | DBMET02568 | |
| 0.016 | 0.506 | 0.093 | MAP kinase 9 inhibitor | 0.093 0.068 DBMET02568 | DBMET02568 | |
| 0.031 | 0.54 | 0.15 | Polo-like kinase-3 inhibitor | 0.15 0.084 DBMET02568 | DBMET02568 | |
| 0.011 | 0.521 | 0.106 | MAP kinase 8 inhibitor | 0.106 0.055 DBMET02568 | DBMET02568 | |
| 0.013 | 0.532 | 0.086 | MAP kinase kinase 1 inhibitor | 0.086 0.077 DBMET02570 | DBMET02570 | |
| 0.011 | 0.546 | 0.106 | MAP kinase kinase inhibitor | 0.105 0.089 DBMET02568 0.106 0.088 DBMET02570 | DBMET02570 | |
| 0.027 | 0.565 | 0.169 | MAP3K9 inhibitor | 0.126 0.103 DBMET02569 0.169 0.036 DBMET02570 | DBMET02570 | |
| 0.009 | 0.549 | 0.12 | Rho-associated kinase II inhibitor | 0.12 0.025 DBMET02568 | DBMET02568 | |
| 0.004 | 0.551 | 0.055 | 5 Hydroxytryptamine 2C agonist | 0.055 0.024 DBMET00341 | DBMET00341 | |
| 0.027 | 0.574 | 0.184 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.184 0.085 DBMET02568 | DBMET02568 | |
| 0.057 | 0.605 | 0.303 | MAP kinase 1 inhibitor | 0.303 0.176 DBMET02568 | DBMET02568 | |
| 0.021 | 0.58 | 0.189 | EphB2 antagonist | 0.189 0.096 DBMET02568 | DBMET02568 | |
| 0.009 | 0.573 | 0.088 | MAP kinase kinase 10 inhibitor | 0.088 0.024 DBMET02568 | DBMET02568 | |
| 0.044 | 0.675 | 0.173 | MAP-kinase-activated kinase 5 inhibitor | 0.173 0.143 DBMET02568 | DBMET02568 | |
| 0.039 | 0.682 | 0.157 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.157 0.135 DBMET02568 | DBMET02568 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |